Method of treating psoriasis by administering IL-22 antibodies, or binding fragments thereof
US7951372B1 · kind B1 · utility
2Cited by
11References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 31, 2007 |
| Grant date | May 31, 2011 |
| Priority date | — |
| Expiry date | Jun 16, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/022
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Inhibitors of IL-22 are disclosed as well as pharmaceutical compositions and methods of using same. The inhibitors include IL-22 antibodies and are useful for treating inflammatory disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.